GI
ZBH icon

GLG Inc’s Zimmer Biomet ZBH Stock Holding History

GLG Inc’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$1.6M Hold
17,719
– – 0.04% 409
2013
Q3 		$1.41M Hold
17,719
– – 0.03% 499
2013
Q2 		$1.29M Buy
+17,719
New +$1.32M 0.03% 400

Other funds holding ZBH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
IIS
Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GLG Inc's ZBH Position: Q4 2013 in Review

GLG Inc held its Zimmer Biomet (ZBH) position steady in Q4 2013 at 17,719 shares worth $1.6M. The position accounts for 0.04% of the portfolio, ranked #409.

GLG Inc first reported a position in ZBH in Q2 2013 and has held it in 3 quarters since. 694 funds tracked by Wall St. Rank hold ZBH as of Q4 2013.

  • GLG Inc held 17,719 shares of Zimmer Biomet worth $1.6M as of Q4 2013.
  • GLG Inc left its Zimmer Biomet share count unchanged in Q4 2013.
  • Zimmer Biomet made up 0.04% of GLG Inc's portfolio in Q4 2013, its #409 holding.
  • GLG Inc first reported a position in Zimmer Biomet in Q2 2013 and has held it in 3 quarters since.
  • 694 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2013.

Based on GLG Inc's 13F filing for Q4 2013, filed 14 Feb 2014.